Additionally, analysis of datasets from the Cancer Dependency Map (DepMap) portal did not reveal a substantial correlation between KRAS expression and KEAP1 expression (Supplemental Figure 4E), indicating that NRF2 activation, in the context of KRAS mutations, does not occur via the conventional KEAP1-dependent pathway. This evidence concerns the gene KEAP1 and cancer.